FFT Wealth Management LLC Has $1.54 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

FFT Wealth Management LLC lessened its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 17,091 shares of the exchange traded fund’s stock after selling 1,025 shares during the period. FFT Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,539,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Addison Advisors LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 27.4% in the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after purchasing an additional 115 shares in the last quarter. Rothschild Investment LLC lifted its stake in shares of SPDR S&P Biotech ETF by 3.0% in the fourth quarter. Rothschild Investment LLC now owns 9,655 shares of the exchange traded fund’s stock valued at $870,000 after buying an additional 282 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of SPDR S&P Biotech ETF by 68.0% during the fourth quarter. IFP Advisors Inc now owns 4,317 shares of the exchange traded fund’s stock valued at $389,000 after buying an additional 1,747 shares during the last quarter. Wealth Alliance increased its position in shares of SPDR S&P Biotech ETF by 4.4% during the fourth quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock worth $368,000 after acquiring an additional 173 shares in the last quarter. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $43,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $88.69 on Wednesday. The business has a 50-day simple moving average of $91.14 and a two-hundred day simple moving average of $95.92. The company has a market capitalization of $6.76 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.